Document Detail

Minimally invasive treatment of raynaud phenomenon: the role of botulinum type a.
MedLine Citation:
PMID:  24286738     Owner:  NLM     Status:  In-Data-Review    
Although the mechanism is unknown, botulinum toxin type A injection may be an effective, localized, nonsurgical treatment option without addictive properties or systemic side effects for the treatment of ischemic digits. Clinical research supports the safety and efficacy of injection of botulinum toxin type A for the treatment of Raynaud phenomenon.
Michael W Neumeister; Kelli Nicole Belangee Webb; Michael Romanelli
Related Documents :
19037738 - Improving livelihoods in east africa through livestock research and extension: reflecti...
24345258 - Evaluating methodological assumptions in comparative effectiveness research: overcoming...
14744218 - Development in midlife.
3684238 - Keeping an eye on the rest of the body.
24688798 - Mechanism of human tooth eruption: review article including a new theory for future stu...
8153028 - Reversal theory: an introduction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hand clinics     Volume:  30     ISSN:  1558-1969     ISO Abbreviation:  Hand Clin     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2013-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8510415     Medline TA:  Hand Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  17-24     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Department of Surgery - Institute for Plastic Surgery, SIU School of Medicine, 747 North Rutledge 3rd Floor, PO Box 19653, Springfield, IL 62794, USA. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Minimally Invasive Finger Fracture Management: Wide-awake Closed Reduction, K-wire Fixation, and Ear...
Next Document:  Collagenase injections for treatment of dupuytren disease.